Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome
| Status: | Completed |
|---|---|
| Conditions: | Women's Studies |
| Therapuetic Areas: | Reproductive |
| Healthy: | No |
| Age Range: | 10 - 18 |
| Updated: | 4/21/2016 |
| Start Date: | January 2014 |
| End Date: | July 2014 |
The purpose of this study is to evaluate the safety and effectiveness of intranasal FE
992097 in children and adults with Prader-Willi Syndrome.
992097 in children and adults with Prader-Willi Syndrome.
Inclusion Criteria:
- Male or female 10-18 years of age (both inclusive)
- Genetically confirmed diagnosis of Prader-Willi Syndrome
- Determined to be in nutritional phase 3 by clinical assessment based on Miller et al,
2011
Exclusion Criteria:
- Known genetic, hormonal, or chromosomal cause of cognitive impairment other than
Prader-Willi Syndrome
- Presence of currently active psychotic symptoms
- Presence of any cardiovascular disorders, epilepsy, frequent migraines or severe
asthma
- Previous diagnosis of autism spectrum disorder by a qualified healthcare provider
- Prior or concomitant use of a selective serotonin reuptake inhibitor (SSRI) or
selective norepinephrine reuptake inhibitor (SNRI), antipsychotic medication,
wakefulness-promoting drug, or thyroid hormone unless dosage has been stable ≥6
months at time of screening
We found this trial at
3
sites
Vanderbilt University Vanderbilt offers undergraduate programs in the liberal arts and sciences, engineering, music, education...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials